Dartmouth Professors Call Out Drug Companies for “Selling a Disease”

The Legal Examiner - Cites an opinion piece published in The Washington Post by Steven Woloshin and Lisa Schwartz, both professors of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice, on testosterone drug risks. In the opinion piece, Woloshin and Schwartz criticized testosterone drug therapy manufacturers for creating "disease-awareness" campaigns that put many men at risk of serious side effects, including heart attack and stroke.